BioMed Realty Announces 31,500 Square Foot Lease Expansion With Risk Management Solutions At The Pacific Research Center

     BioMed Realty Announces 31,500 Square Foot Lease Expansion With Risk
             Management Solutions At The Pacific Research Center

Over 82,000 Square Feet of New Leasing Signed at PRC in 2013

PR Newswire

SAN DIEGO, April 8, 2013

SAN DIEGO, April 8, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR)
announced today that Risk Management Solutions, Inc. ("RMS"), a leader in risk
modeling for businesses, has leased an additional 31,500 square feet at its
Pacific Research Center in Newark, California. As a result of this lease
expansion, RMS' occupancy at Pacific Research Center North will increase to
approximately 134,000 square feet, all of which extends through December 31,

With the signing of the RMS lease expansion, in addition to two recent new
leasing transactions totaling approximately 50,800 square feet, BioMed Realty
has executed over 82,000 square feet of new leases during 2013 at Pacific
Research Center, which is now 72% leased.

"We are excited that RMS has expanded their presence at the Pacific Research
Center and look forward to providing real estate solutions in support of their
efforts to help organizations understand and manage risk exposure," said Alan
D. Gold, Chairman and Chief Executive Officer of BioMed Realty. "With over
400,000 square feet leased in the past 15 months, PRC is a vibrant,
amenity-rich campus in close proximity to the life science and high-tech
markets in the San Francisco Bay Area that continues to attract a broad array
of high-quality tenants."

The Pacific Research Center campus is comprised of Pacific Research Center
North, Pacific Research Center South and Pacific Industrial Center.

About BioMed Realty Trust

BioMed Realty delivers optimal real estate solutions for biotechnology and
pharmaceutical companies, scientific research institutions, government
agencies and other entities involved in the life science industry. BioMed
Realty owns or has interests in properties comprising approximately 13.5
million rentable square feet. The company's properties are located
predominantly in the major U.S. life science markets of Boston, San Francisco,
Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle, which have
well-established reputations as centers for scientific research. Additional
information is available at

This press release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 based on current
expectations, forecasts and assumptions that involve risks and uncertainties
that could cause actual outcomes and results to differ materially. These risks
and uncertainties include, without limitation: general risks affecting the
real estate industry (including, without limitation, the inability to enter
into or renew leases, dependence on tenants' financial condition, and
competition from other developers, owners and operators of real estate);
adverse economic or real estate developments in the life science industry or
the company's target markets; risks associated with the availability and terms
of financing, the use of debt to fund acquisitions, developments and other
investments, and the ability to refinance indebtedness as it comes due;
failure to maintain the company's investment grade credit ratings with the
ratings agencies; failure to manage effectively the company's growth and
expansion into new markets, or to complete or integrate acquisitions and
developments successfully; reductions in asset valuations and related
impairment charges; risks and uncertainties affecting property development and
construction; risks associated with downturns in foreign, domestic and local
economies, changes in interest rates and foreign currency exchange rates, and
volatility in the securities markets; ownership of properties outside of the
United States that subject the company to different and potentially greater
risks than those associated with the company's domestic operations; risks
associated with the company's investments in loans, including borrower
defaults and potential principal losses; potential liability for uninsured
losses and environmental contamination; risks associated with the company's
potential failure to qualify as a REIT under the Internal Revenue Code of
1986, as amended, and possible adverse changes in tax and environmental laws;
and risks associated with the company's dependence on key personnel whose
continued service is not guaranteed. For a further list and description of
such risks and uncertainties, see the reports filed by the company with the
Securities and Exchange Commission, including the company's most recent annual
report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims
any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or

SOURCE BioMed Realty Trust, Inc.

Contact: Rick Howe, Senior Director, Corporate Communications, (858) 207-5859,
Press spacebar to pause and continue. Press esc to stop.